File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Implementation of Statistical Innovation in a Pharmaceutical Company

TitleImplementation of Statistical Innovation in a Pharmaceutical Company
Authors
KeywordsCollaboration
Commercialization
Innovation
Invention
Statistics
Issue Date1-Jan-2024
PublisherTaylor and Francis Group
Citation
Statistics in Biopharmaceutical Research, 2024 How to Cite?
AbstractInnovation, defined as the successful implementation at scale of a new invention, is key for continued success of the drug development enterprise. In this article we focus on statistical innovation in the pharmaceutical industry. We discuss both components, invention and implementation at scale, typically called commercialization, of innovation for statistical methods. These concepts are illustrated using three examples that we successfully implemented in our company. We summarize factors that foster or hinder invention and commercialization. A discussion of the mindset we consider supportive of innovation and how organizational leaders and professional organizations can generate an environment that fosters innovation concludes the article.
Persistent Identifierhttp://hdl.handle.net/10722/350442

 

DC FieldValueLanguage
dc.contributor.authorRufibach, Kaspar-
dc.contributor.authorWolbers, Marcel-
dc.contributor.authorDevenport, Jenny-
dc.contributor.authorYung, Godwin-
dc.contributor.authorHarbron, Chris-
dc.contributor.authorBedding, Alun-
dc.contributor.authorHuang, Zhiyue-
dc.contributor.authorLin, Ray-
dc.contributor.authorPang, Herbert-
dc.contributor.authorSabanés Bové, Daniel-
dc.contributor.authorWang, Jianmei-
dc.date.accessioned2024-10-29T00:31:36Z-
dc.date.available2024-10-29T00:31:36Z-
dc.date.issued2024-01-01-
dc.identifier.citationStatistics in Biopharmaceutical Research, 2024-
dc.identifier.urihttp://hdl.handle.net/10722/350442-
dc.description.abstractInnovation, defined as the successful implementation at scale of a new invention, is key for continued success of the drug development enterprise. In this article we focus on statistical innovation in the pharmaceutical industry. We discuss both components, invention and implementation at scale, typically called commercialization, of innovation for statistical methods. These concepts are illustrated using three examples that we successfully implemented in our company. We summarize factors that foster or hinder invention and commercialization. A discussion of the mindset we consider supportive of innovation and how organizational leaders and professional organizations can generate an environment that fosters innovation concludes the article.-
dc.languageeng-
dc.publisherTaylor and Francis Group-
dc.relation.ispartofStatistics in Biopharmaceutical Research-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCollaboration-
dc.subjectCommercialization-
dc.subjectInnovation-
dc.subjectInvention-
dc.subjectStatistics-
dc.titleImplementation of Statistical Innovation in a Pharmaceutical Company-
dc.typeArticle-
dc.identifier.doi10.1080/19466315.2024.2327291-
dc.identifier.scopuseid_2-s2.0-85190538348-
dc.identifier.eissn1946-6315-
dc.identifier.issnl1946-6315-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats